Inrig Jula bought TVTX

September 15, 2026 · Form 4 insider transaction

Inrig Jula bought 32,395 shares of Travere Therapeutics, Inc. at $8.93 per share, a transaction worth $289.3K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.